speb/financial-data huggingface dataset:
EXEL cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -23300000.00
EXEL balance_sheet (annual, 2022-12-31) — Net PPE: 401202000.00
EXEL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -27706000.00
EXEL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2424743000.00
EXEL balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 231110000.00
EXEL balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 6582000.00
EXEL balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 6582000.00
EXEL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 231110000.00
EXEL income_statement (annual, 2022-12-31) — Normalized EBITDA: 222359000.00
EXEL income_statement (annual, 2022-12-31) — Normalized Income: 182282000.00
EXEL cash_flow (annual, 2022-12-31) — Operating Cash Flow: 362614000.00
EXEL income_statement (annual, 2022-12-31) — Operating Income: 201484000.00
EXEL income_statement (annual, 2022-12-31) — Operating Revenue: 2160988000.00
EXEL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 323951000.00
EXEL balance_sheet (annual, 2022-12-31) — Other Current Assets: 62211000.00
EXEL balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 78924000.00
EXEL balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -14521000.00
EXEL income_statement (annual, 2022-12-31) — Other Income Expense: -197000.00
EXEL cash_flow (annual, 2022-12-31) — Other Non Cash Items: 125040000.00
EXEL balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 68533000.00
EXEL income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -197000.00
EXEL balance_sheet (annual, 2022-12-31) — Other Properties: 330184000.00
EXEL balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 807273000.00
EXEL balance_sheet (annual, 2022-12-31) — Payables: 32667000.00
EXEL balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 117927000.00
EXEL balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 77158000.00
EXEL balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
EXEL income_statement (annual, 2022-12-31) — Pretax Income: 234352000.00
EXEL cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 23886000.00
EXEL balance_sheet (annual, 2022-12-31) — Properties: 0.00
EXEL cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -110750000.00
EXEL cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1450716000.00
EXEL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -27706000.00
EXEL balance_sheet (annual, 2022-12-31) — Receivables: 214784000.00
EXEL income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 57909000.00
EXEL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 20875000.00
EXEL cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
EXEL income_statement (annual, 2022-12-31) — Research And Development: 891813000.00
EXEL income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
EXEL balance_sheet (annual, 2022-12-31) — Retained Earnings: -34225000.00
EXEL cash_flow (annual, 2022-12-31) — Sale Of Investment: 1064758000.00
EXEL income_statement (annual, 2022-12-31) — Selling General And Administration: 459856000.00
EXEL balance_sheet (annual, 2022-12-31) — Share Issued: 323951000.00
EXEL income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
EXEL cash_flow (annual, 2022-12-31) — Stock Based Compensation: 107574000.00
EXEL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2488427000.00
EXEL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2424743000.00
EXEL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
EXEL income_statement (annual, 2022-12-31) — Tax Provision: 52070000.00
EXEL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
EXEL balance_sheet (annual, 2022-12-31) — Total Assets: 3071489000.00
EXEL balance_sheet (annual, 2022-12-31) — Total Capitalization: 2488427000.00
EXEL balance_sheet (annual, 2022-12-31) — Total Debt: 190170000.00
EXEL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 2488427000.00
EXEL income_statement (annual, 2022-12-31) — Total Expenses: 1409578000.00
EXEL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 583062000.00
EXEL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1452727000.00
EXEL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 258703000.00
EXEL income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 201484000.00
EXEL income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
EXEL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
EXEL balance_sheet (annual, 2022-12-31) — Working Capital: 1294403000.00
EXEL income_statement (annual, 2023-12-31) — +Operating Expense: 1586776000.00
EXEL income_statement (annual, 2023-12-31) — +Total Revenue: 1830208000.00
EXEL balance_sheet (annual, 2023-12-31) — Accounts Payable: 33768000.00
EXEL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 237407000.00
EXEL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -80390000.00
EXEL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2440710000.00
EXEL cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
EXEL income_statement (annual, 2023-12-31) — Basic Average Shares: 318151000.00
EXEL income_statement (annual, 2023-12-31) — Basic EPS: 0.65
EXEL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 502677000.00
EXEL cash_flow (annual, 2023-12-31) — Capital Expenditure: -162969000.00
EXEL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 189944000.00
EXEL balance_sheet (annual, 2023-12-31) — Capital Stock: 303000.00
EXEL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 262994000.00
EXEL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 995302000.00
EXEL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -546052000.00
EXEL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -26955000.00
EXEL cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 333324000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Account Payable: 50106000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1345000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Inventory: -12977000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -3140000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Payable: 50106000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 51451000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -29824000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Receivables: -22623000.00
EXEL cash_flow (annual, 2023-12-31) — Change In Working Capital: -13973000.00
EXEL cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -22623000.00
EXEL cash_flow (annual, 2023-12-31) — Changes In Cash: -239683000.00
EXEL balance_sheet (annual, 2023-12-31) — Common Stock: 303000.00
EXEL balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2263912000.00
EXEL cash_flow (annual, 2023-12-31) — Common Stock Payments: -550378000.00
EXEL balance_sheet (annual, 2023-12-31) — Construction In Progress: 24465000.00
EXEL income_statement (annual, 2023-12-31) — Cost Of Revenue: 72547000.00
EXEL balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 99148000.00
EXEL balance_sheet (annual, 2023-12-31) — Current Assets: 1317958000.00
EXEL balance_sheet (annual, 2023-12-31) — Current Liabilities: 394277000.00
EXEL balance_sheet (annual, 2023-12-31) — Current Provisions: 59619000.00
EXEL cash_flow (annual, 2023-12-31) — Deferred Income Tax: -133209000.00
EXEL cash_flow (annual, 2023-12-31) — Deferred Tax: -133209000.00
EXEL cash_flow (annual, 2023-12-31) — Depreciation: 25717000.00
EXEL cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 25717000.00
EXEL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 25717000.00
EXEL income_statement (annual, 2023-12-31) — Diluted Average Shares: 321464000.00
EXEL income_statement (annual, 2023-12-31) — Diluted EPS: 0.65
EXEL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 207765000.00
EXEL income_statement (annual, 2023-12-31) — EBIT: 170885000.00
EXEL income_statement (annual, 2023-12-31) — EBITDA: 196602000.00
EXEL cash_flow (annual, 2023-12-31) — End Cash Position: 262994000.00
EXEL cash_flow (annual, 2023-12-31) — Financing Cash Flow: -546052000.00
EXEL cash_flow (annual, 2023-12-31) — Free Cash Flow: 170355000.00
EXEL balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -3750000.00
EXEL income_statement (annual, 2023-12-31) — General And Administrative Expense: 542705000.00
EXEL balance_sheet (annual, 2023-12-31) — Goodwill: 63684000.00
EXEL balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 63684000.00
EXEL balance_sheet (annual, 2023-12-31) — Gross PPE: 551243000.00
EXEL income_statement (annual, 2023-12-31) — Gross Profit: 1757661000.00
EXEL income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
EXEL cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 185658000.00
EXEL income_statement (annual, 2023-12-31) — Interest Income: 86543000.00
EXEL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 86543000.00
EXEL balance_sheet (annual, 2023-12-31) — Inventory: 17323000.00
EXEL balance_sheet (annual, 2023-12-31) — Invested Capital: 2263912000.00
EXEL cash_flow (annual, 2023-12-31) — Investing Cash Flow: -26955000.00
EXEL balance_sheet (annual, 2023-12-31) — Investments And Advances: 728717000.00
EXEL balance_sheet (annual, 2023-12-31) — Leases: 89038000.00
EXEL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 189944000.00
EXEL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 189944000.00
EXEL balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 44714000.00
EXEL cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -550378000.00
EXEL income_statement (annual, 2023-12-31) — Net Income: 207765000.00
EXEL income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 207765000.00
EXEL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 207765000.00
EXEL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 207765000.00
EXEL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 207765000.00
EXEL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 207765000.00
EXEL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 207765000.00
EXEL cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -122500000.00
EXEL income_statement (annual, 2023-12-31) — Net Interest Income: 86543000.00
EXEL cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 136014000.00
EXEL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 86543000.00
EXEL cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -29122000.00
EXEL balance_sheet (annual, 2023-12-31) — Net PPE: 470853000.00
EXEL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -40469000.00
EXEL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 2200228000.00
EXEL balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 361145000.00
EXEL balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 361145000.00
EXEL income_statement (annual, 2023-12-31) — Normalized EBITDA: 196602000.00
EXEL income_statement (annual, 2023-12-31) — Normalized Income: 207765000.00
EXEL cash_flow (annual, 2023-12-31) — Operating Cash Flow: 333324000.00
EXEL income_statement (annual, 2023-12-31) — Operating Income: 170885000.00
EXEL income_statement (annual, 2023-12-31) — Operating Revenue: 2473862000.00
EXEL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 302793000.00
EXEL balance_sheet (annual, 2023-12-31) — Other Current Assets: 67926000.00
EXEL balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 108417000.00
EXEL balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -3750000.00
EXEL income_statement (annual, 2023-12-31) — Other Gand A: 470680000.00
EXEL income_statement (annual, 2023-12-31) — Other Income Expense: 93000.00
EXEL cash_flow (annual, 2023-12-31) — Other Non Cash Items: 140679000.00
EXEL balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 94224000.00
EXEL income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 93000.00
EXEL balance_sheet (annual, 2023-12-31) — Other Properties: 393026000.00
EXEL balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 732308000.00
EXEL balance_sheet (annual, 2023-12-31) — Payables: 33768000.00
EXEL balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 132916000.00
EXEL balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 93325000.00
EXEL balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
EXEL income_statement (annual, 2023-12-31) — Pretax Income: 257521000.00
EXEL cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 33448000.00
EXEL balance_sheet (annual, 2023-12-31) — Properties: 0.00
EXEL cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -122500000.00
EXEL cash_flow (annual, 2023-12-31) — Purchase Of Investment: -902468000.00
EXEL cash_flow (annual, 2023-12-31) — Purchase Of PPE: -40469000.00
EXEL balance_sheet (annual, 2023-12-31) — Receivables: 237407000.00
EXEL income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 72547000.00
EXEL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 25717000.00
EXEL cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -550378000.00
EXEL income_statement (annual, 2023-12-31) — Research And Development: 1044071000.00
EXEL income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
EXEL balance_sheet (annual, 2023-12-31) — Retained Earnings: -173351000.00
EXEL income_statement (annual, 2023-12-31) — Salaries And Wages: 72025000.00
EXEL cash_flow (annual, 2023-12-31) — Sale Of Investment: 1038482000.00
EXEL income_statement (annual, 2023-12-31) — Selling General And Administration: 542705000.00
EXEL balance_sheet (annual, 2023-12-31) — Share Issued: 302793000.00
EXEL income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
EXEL cash_flow (annual, 2023-12-31) — Stock Based Compensation: 106345000.00
EXEL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 2263912000.00
EXEL balance_sheet (annual, 2023-12-31) — Tangible Book Value: 2200228000.00
EXEL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
EXEL income_statement (annual, 2023-12-31) — Tax Provision: 49756000.00
EXEL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.19
EXEL balance_sheet (annual, 2023-12-31) — Total Assets: 2942357000.00
EXEL balance_sheet (annual, 2023-12-31) — Total Capitalization: 2263912000.00
EXEL balance_sheet (annual, 2023-12-31) — Total Debt: 189944000.00
EXEL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 2263912000.00
EXEL income_statement (annual, 2023-12-31) — Total Expenses: 1659323000.00
EXEL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 678445000.00
EXEL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1624399000.00
EXEL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 284168000.00
EXEL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 170885000.00
EXEL income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
EXEL income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
EXEL balance_sheet (annual, 2023-12-31) — Working Capital: 923681000.00
EXEL cash_flow (quarterly, 2024-09-30) — Depreciation: 7454000.00
EXEL income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 51672000.00
EXEL income_statement (annual, 2024-12-31) — +Operating Expense: 1402536000.00
EXEL income_statement (annual, 2024-12-31) — +Total Revenue: 2168701000.00
EXEL balance_sheet (annual, 2024-12-31) — Accounts Payable: 38191000.00
EXEL balance_sheet (annual, 2024-12-31) — Accounts Receivable: 265437000.00
EXEL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -100732000.00
EXEL balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -100732000.00
EXEL balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2343915000.00
EXEL cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 64391000.00
EXEL cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 153000.00
EXEL income_statement (annual, 2024-12-31) — Basic Average Shares: 290030000.00
EXEL income_statement (annual, 2024-12-31) — Basic EPS: 1.80
EXEL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 262994000.00
EXEL cash_flow (annual, 2024-12-31) — Capital Expenditure: -66185000.00
EXEL balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 190823000.00
EXEL balance_sheet (annual, 2024-12-31) — Capital Stock: 282000.00
EXEL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 217374000.00
EXEL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1111276000.00
EXEL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -628808000.00
EXEL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -116783000.00
EXEL cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 699971000.00
EXEL cash_flow (annual, 2024-12-31) — Change In Account Payable: -21886000.00
EXEL cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -149000.00
EXEL cash_flow (annual, 2024-12-31) — Change In Inventory: 5453000.00
EXEL cash_flow (annual, 2024-12-31) — Change In Payable: -21886000.00
EXEL cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -22035000.00
EXEL cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 31079000.00
EXEL cash_flow (annual, 2024-12-31) — Change In Receivables: -27950000.00
EXEL cash_flow (annual, 2024-12-31) — Change In Working Capital: -13453000.00
EXEL cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -27950000.00
EXEL cash_flow (annual, 2024-12-31) — Changes In Cash: -45620000.00
EXEL balance_sheet (annual, 2024-12-31) — Common Stock: 282000.00
EXEL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2244203000.00
EXEL cash_flow (annual, 2024-12-31) — Common Stock Payments: -652033000.00
EXEL balance_sheet (annual, 2024-12-31) — Construction In Progress: 2875000.00
EXEL balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 2875000.00
EXEL income_statement (annual, 2024-12-31) — Cost Of Revenue: 76216000.00
EXEL balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 98360000.00
EXEL balance_sheet (annual, 2024-12-31) — Current Assets: 1467579000.00
EXEL balance_sheet (annual, 2024-12-31) — Current Liabilities: 403769000.00
EXEL balance_sheet (annual, 2024-12-31) — Current Provisions: 62376000.00
EXEL cash_flow (annual, 2024-12-31) — Deferred Income Tax: -59458000.00
EXEL cash_flow (annual, 2024-12-31) — Deferred Tax: -59458000.00
EXEL cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 28803000.00
EXEL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 28803000.00
EXEL income_statement (annual, 2024-12-31) — Diluted Average Shares: 296132000.00
EXEL income_statement (annual, 2024-12-31) — Diluted EPS: 1.76
EXEL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 521267000.00
EXEL income_statement (annual, 2024-12-31) — EBIT: 689949000.00
EXEL income_statement (annual, 2024-12-31) — EBITDA: 718752000.00
EXEL cash_flow (annual, 2024-12-31) — End Cash Position: 217374000.00
EXEL cash_flow (annual, 2024-12-31) — Financing Cash Flow: -628808000.00
EXEL cash_flow (annual, 2024-12-31) — Free Cash Flow: 633786000.00
EXEL balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1347000.00
EXEL income_statement (annual, 2024-12-31) — General And Administrative Expense: 492128000.00
EXEL balance_sheet (annual, 2024-12-31) — Goodwill: 63684000.00
EXEL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 63684000.00
EXEL balance_sheet (annual, 2024-12-31) — Gross PPE: 459841000.00
EXEL income_statement (annual, 2024-12-31) — Gross Profit: 2092485000.00
EXEL income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 64391000.00
EXEL income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 153000.00
EXEL cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 170482000.00
EXEL income_statement (annual, 2024-12-31) — Interest Income: 77156000.00
EXEL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 77156000.00
EXEL balance_sheet (annual, 2024-12-31) — Inventory: 22388000.00
EXEL balance_sheet (annual, 2024-12-31) — Invested Capital: 2244203000.00
EXEL cash_flow (annual, 2024-12-31) — Investing Cash Flow: -116783000.00
EXEL balance_sheet (annual, 2024-12-31) — Investments And Advances: 637291000.00
EXEL balance_sheet (annual, 2024-12-31) — Leases: 108277000.00
EXEL balance_sheet (quarterly, 2024-12-31) — Leases: 108277000.00
EXEL balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 190823000.00
EXEL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 190823000.00
EXEL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 38536000.00
EXEL balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 38536000.00
EXEL cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -652033000.00
EXEL income_statement (annual, 2024-12-31) — Net Income: 521267000.00
EXEL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 521267000.00
EXEL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 521267000.00
EXEL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 521267000.00
EXEL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 521267000.00
EXEL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 521267000.00
EXEL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 521267000.00
EXEL cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -37750000.00
EXEL income_statement (annual, 2024-12-31) — Net Interest Income: 77156000.00
EXEL cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -50598000.00
EXEL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 77156000.00
EXEL cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -38625000.00
EXEL balance_sheet (annual, 2024-12-31) — Net PPE: 359109000.00
EXEL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -28435000.00
EXEL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2180519000.00
EXEL balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 420027000.00
EXEL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 420027000.00
EXEL income_statement (annual, 2024-12-31) — Normalized EBITDA: 804084000.00
EXEL income_statement (annual, 2024-12-31) — Normalized Income: 586545980.00
EXEL cash_flow (annual, 2024-12-31) — Operating Cash Flow: 699971000.00
EXEL income_statement (annual, 2024-12-31) — Operating Income: 689949000.00
EXEL income_statement (annual, 2024-12-31) — Operating Revenue: 2877552000.00
EXEL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 281732000.00
EXEL balance_sheet (annual, 2024-12-31) — Other Current Assets: 68478000.00
EXEL balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 95012000.00
EXEL balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1347000.00
EXEL income_statement (annual, 2024-12-31) — Other Gand A: 428962000.00
EXEL income_statement (annual, 2024-12-31) — Other Income Expense: -85465000.00
EXEL cash_flow (annual, 2024-12-31) — Other Non Cash Items: 64585000.00
EXEL balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 108895000.00
EXEL income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -133000.00
EXEL balance_sheet (annual, 2024-12-31) — Other Properties: 310153000.00
EXEL balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 893902000.00
EXEL balance_sheet (annual, 2024-12-31) — Payables: 38191000.00
EXEL balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 136551000.00
EXEL balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 109830000.00
EXEL balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
EXEL income_statement (annual, 2024-12-31) — Pretax Income: 681640000.00
EXEL cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 61850000.00
EXEL balance_sheet (annual, 2024-12-31) — Properties: 0.00
EXEL balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
EXEL cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -37750000.00
EXEL cash_flow (annual, 2024-12-31) — Purchase Of Investment: -927905000.00
EXEL cash_flow (annual, 2024-12-31) — Purchase Of PPE: -28435000.00
EXEL balance_sheet (annual, 2024-12-31) — Receivables: 265437000.00
EXEL income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 76216000.00
EXEL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 28803000.00
EXEL cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -652033000.00
EXEL income_statement (annual, 2024-12-31) — Research And Development: 910408000.00
EXEL income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 20941000.00
EXEL income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 101000.00
EXEL balance_sheet (annual, 2024-12-31) — Retained Earnings: -98647000.00
EXEL income_statement (annual, 2024-12-31) — Salaries And Wages: 63166000.00
EXEL cash_flow (annual, 2024-12-31) — Sale Of Investment: 877307000.00
EXEL income_statement (annual, 2024-12-31) — Selling General And Administration: 492128000.00
EXEL balance_sheet (annual, 2024-12-31) — Share Issued: 281732000.00
EXEL income_statement (annual, 2024-12-31) — Special Income Charges: -85332000.00
EXEL income_statement (quarterly, 2024-12-31) — Special Income Charges: -254000.00
EXEL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 93836000.00
EXEL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2244203000.00
EXEL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2180519000.00
EXEL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -20053020.00
EXEL income_statement (annual, 2024-12-31) — Tax Provision: 160373000.00
EXEL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.24
EXEL balance_sheet (annual, 2024-12-31) — Total Assets: 2947690000.00
EXEL balance_sheet (annual, 2024-12-31) — Total Capitalization: 2244203000.00
EXEL balance_sheet (annual, 2024-12-31) — Total Debt: 190823000.00
EXEL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2244203000.00
EXEL income_statement (annual, 2024-12-31) — Total Expenses: 1478752000.00
EXEL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 703487000.00
EXEL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1480111000.00
EXEL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 299718000.00
EXEL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 604617000.00
EXEL income_statement (annual, 2024-12-31) — Total Unusual Items: -85332000.00
EXEL income_statement (quarterly, 2024-12-31) — Total Unusual Items: -254000.00
EXEL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -85332000.00
EXEL income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -254000.00
EXEL balance_sheet (annual, 2024-12-31) — Working Capital: 1063810000.00
EXEL income_statement (quarterly, 2025-03-31) — +Operating Expense: 349416000.00
EXEL income_statement (quarterly, 2025-03-31) — +Total Revenue: 555447000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 42840000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 281637000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2292033000.00
EXEL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 278804000.00
EXEL income_statement (quarterly, 2025-03-31) — Basic EPS: 0.57
EXEL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 217374000.00
EXEL cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -22452000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 187125000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 275000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 183752000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1031316000.00
EXEL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -294823000.00
EXEL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 49764000.00
EXEL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 211437000.00
EXEL cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 8501000.00
EXEL cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 4605000.00
EXEL cash_flow (quarterly, 2025-03-31) — Change In Inventory: -71000.00
EXEL cash_flow (quarterly, 2025-03-31) — Change In Payable: 8501000.00
EXEL cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 13106000.00
EXEL cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 20320000.00
EXEL cash_flow (quarterly, 2025-03-31) — Change In Receivables: -16119000.00
EXEL cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 17236000.00
EXEL cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -16119000.00
EXEL cash_flow (quarterly, 2025-03-31) — Changes In Cash: -33622000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Common Stock: 275000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2131024000.00
EXEL cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -283934000.00
EXEL income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 19172000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 83124000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Current Assets: 1396502000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 399102000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Current Provisions: 57840000.00
EXEL cash_flow (quarterly, 2025-03-31) — Depreciation: 7345000.00
EXEL cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 7345000.00
EXEL cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 7345000.00
EXEL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 288177000.00
EXEL income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.55
EXEL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 159616000.00
EXEL income_statement (quarterly, 2025-03-31) — EBIT: 186859000.00
EXEL income_statement (quarterly, 2025-03-31) — EBITDA: 194204000.00
EXEL cash_flow (quarterly, 2025-03-31) — End Cash Position: 183752000.00
EXEL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -294823000.00
EXEL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 188985000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 2010000.00
EXEL income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 137183000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Goodwill: 63684000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 63684000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Gross PPE: 338575000.00
EXEL income_statement (quarterly, 2025-03-31) — Gross Profit: 536275000.00
EXEL income_statement (quarterly, 2025-03-31) — Interest Income: 19076000.00
EXEL income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 19076000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Inventory: 24853000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2131024000.00
EXEL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 49764000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 619441000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 187125000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 187125000.00
EXEL cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -283934000.00
EXEL income_statement (quarterly, 2025-03-31) — Net Income: 159616000.00
EXEL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 159616000.00
EXEL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 159616000.00
EXEL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 159616000.00
EXEL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 159616000.00
EXEL cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 159616000.00
EXEL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 159616000.00
EXEL cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -19500000.00
EXEL income_statement (quarterly, 2025-03-31) — Net Interest Income: 19076000.00
EXEL cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 72216000.00
EXEL income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 19076000.00
EXEL cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -22516000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Net PPE: 338575000.00
EXEL cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -2952000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2067340000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 419045000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 419045000.00
EXEL income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 194204000.00
EXEL income_statement (quarterly, 2025-03-31) — Normalized Income: 159616000.00
EXEL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 211437000.00
EXEL income_statement (quarterly, 2025-03-31) — Operating Income: 186859000.00
EXEL income_statement (quarterly, 2025-03-31) — Operating Revenue: 763875000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 275583955.00
EXEL balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 58696000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 125551000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 2010000.00
EXEL income_statement (quarterly, 2025-03-31) — Other Gand A: 120775000.00
EXEL income_statement (quarterly, 2025-03-31) — Other Income Expense: -245000.00
EXEL cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1310000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 119996000.00
EXEL income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -245000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Other Properties: 338575000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 847564000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Payables: 42840000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 125964000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 89747000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
EXEL income_statement (quarterly, 2025-03-31) — Pretax Income: 205690000.00
EXEL cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 11627000.00
EXEL cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -19500000.00
EXEL cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -186701000.00
EXEL cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -2952000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Receivables: 281637000.00
EXEL income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 19172000.00
EXEL income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7345000.00
EXEL cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -283934000.00
EXEL income_statement (quarterly, 2025-03-31) — Research And Development: 212233000.00
EXEL income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
EXEL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -163294000.00
EXEL income_statement (quarterly, 2025-03-31) — Salaries And Wages: 16408000.00
EXEL cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 258917000.00
EXEL income_statement (quarterly, 2025-03-31) — Selling General And Administration: 137183000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Share Issued: 275583955.00
EXEL income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
EXEL cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 25930000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2131024000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2067340000.00
EXEL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
EXEL income_statement (quarterly, 2025-03-31) — Tax Provision: 46074000.00
EXEL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
EXEL balance_sheet (quarterly, 2025-03-31) — Total Assets: 2837247000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2131024000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Total Debt: 187125000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2131024000.00
EXEL income_statement (quarterly, 2025-03-31) — Total Expenses: 368588000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 706223000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1440745000.00
EXEL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 307121000.00
EXEL income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 186859000.00
EXEL income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
EXEL income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
EXEL balance_sheet (quarterly, 2025-03-31) — Working Capital: 997400000.00
EXEL income_statement (quarterly, 2025-06-30) — +Operating Expense: 335215000.00
EXEL income_statement (quarterly, 2025-06-30) — +Total Revenue: 568261000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 25821000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 292354000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2251456000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 594652000.00
EXEL income_statement (quarterly, 2025-06-30) — Basic Average Shares: 272583000.00
EXEL income_statement (quarterly, 2025-06-30) — Basic EPS: 0.68
EXEL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 183752000.00
EXEL cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3588000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 179842000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 270000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 164433000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 791098000.00
EXEL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -316343000.00
EXEL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 248031000.00
EXEL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 48993000.00
EXEL cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -63508000.00
EXEL cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -3964000.00
EXEL cash_flow (quarterly, 2025-06-30) — Change In Inventory: 2639000.00
EXEL cash_flow (quarterly, 2025-06-30) — Change In Payable: -63508000.00
EXEL cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -67472000.00
EXEL cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -104706000.00
EXEL cash_flow (quarterly, 2025-06-30) — Change In Receivables: -10718000.00
EXEL cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -180257000.00
EXEL cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -10718000.00
EXEL cash_flow (quarterly, 2025-06-30) — Changes In Cash: -19319000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Common Stock: 270000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2033536000.00
EXEL cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -301924000.00
EXEL income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 19470000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 79399000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Current Assets: 1180764000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 336111000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Current Provisions: 57276000.00
EXEL cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7342000.00
EXEL cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7342000.00
EXEL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 284393000.00
EXEL income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.65
EXEL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 184848000.00
EXEL income_statement (quarterly, 2025-06-30) — EBIT: 213576000.00
EXEL income_statement (quarterly, 2025-06-30) — EBITDA: 220918000.00
EXEL cash_flow (quarterly, 2025-06-30) — End Cash Position: 164433000.00
EXEL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -316343000.00
EXEL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 45405000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1349000.00
EXEL income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 134859000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Goodwill: 63684000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 63684000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Gross PPE: 419740000.00
EXEL income_statement (quarterly, 2025-06-30) — Gross Profit: 548791000.00
EXEL income_statement (quarterly, 2025-06-30) — Interest Income: 16789000.00
EXEL income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 16789000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Inventory: 23483000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2033536000.00
EXEL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 248031000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 594652000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 594652000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 179842000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 179842000.00
EXEL cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -301924000.00
EXEL income_statement (quarterly, 2025-06-30) — Net Income: 184848000.00
EXEL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 184848000.00
EXEL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 184848000.00
EXEL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 184848000.00
EXEL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 184848000.00
EXEL cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 184848000.00
EXEL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 184848000.00
EXEL cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -750000.00
EXEL income_statement (quarterly, 2025-06-30) — Net Interest Income: 16789000.00
EXEL cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 251619000.00
EXEL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 16789000.00
EXEL cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -40502000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Net PPE: 419740000.00
EXEL cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2838000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1969852000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 419241000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 419241000.00
EXEL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 220918000.00
EXEL income_statement (quarterly, 2025-06-30) — Normalized Income: 184848000.00
EXEL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 48993000.00
EXEL income_statement (quarterly, 2025-06-30) — Operating Income: 213576000.00
EXEL income_statement (quarterly, 2025-06-30) — Operating Revenue: 793527000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 270132000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 73829000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 101365000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1349000.00
EXEL income_statement (quarterly, 2025-06-30) — Other Gand A: 112931000.00
EXEL income_statement (quarterly, 2025-06-30) — Other Income Expense: 50000.00
EXEL cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 989000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 128592000.00
EXEL income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 50000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Other Properties: 419740000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 626665000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Payables: 25821000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 105220000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 72250000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
EXEL income_statement (quarterly, 2025-06-30) — Pretax Income: 230415000.00
EXEL cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 26083000.00
EXEL cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -750000.00
EXEL cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -101485000.00
EXEL cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2838000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Receivables: 292354000.00
EXEL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 19470000.00
EXEL income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7342000.00
EXEL cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -301924000.00
EXEL income_statement (quarterly, 2025-06-30) — Research And Development: 200356000.00
EXEL income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
EXEL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -219539000.00
EXEL income_statement (quarterly, 2025-06-30) — Salaries And Wages: 21928000.00
EXEL cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 353104000.00
EXEL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 134859000.00
EXEL balance_sheet (quarterly, 2025-06-30) — Share Issued: 270132000.00